GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (MIC:REGN-RM) » Definitions » Cyclically Adjusted Book per Share

Regeneron Pharmaceuticals (MIC:REGN-RM) Cyclically Adjusted Book per Share : ₽0.00 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Regeneron Pharmaceuticals Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Regeneron Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2025 was ₽22,436.364. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₽0.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Regeneron Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 22.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 28.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 31.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 33.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Regeneron Pharmaceuticals was 35.90% per year. The lowest was -4.00% per year. And the median was 9.70% per year.

As of today (2025-07-18), Regeneron Pharmaceuticals's current stock price is ₽0.00. Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₽0.00. Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Regeneron Pharmaceuticals was 61.08. The lowest was 3.43. And the median was 11.02.


Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Chart

Regeneron Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Regeneron Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regeneron Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Regeneron Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=22436.364/134.9266*134.9266
=22,436.364

Current CPI (Mar. 2025) = 134.9266.

Regeneron Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201506 1,792.606 100.684 2,402.273
201509 2,082.028 100.392 2,798.254
201512 2,557.537 99.792 3,457.976
201603 2,427.003 100.470 3,259.341
201606 2,470.909 101.688 3,278.568
201609 2,686.350 101.861 3,558.379
201612 2,532.575 101.863 3,354.631
201703 2,563.598 102.862 3,362.728
201706 3,062.324 103.349 3,997.993
201709 3,261.785 104.136 4,226.235
201712 3,286.496 104.011 4,263.350
201803 3,486.525 105.290 4,467.919
201806 4,182.733 106.317 5,308.304
201809 4,765.335 106.507 6,036.901
201812 5,585.179 105.998 7,109.473
201903 5,594.327 107.251 7,037.949
201906 5,603.615 108.070 6,996.208
201909 6,036.895 108.329 7,519.083
201912 6,231.951 108.420 7,755.536
202003 8,607.248 108.902 10,664.194
202006 5,977.360 108.767 7,414.957
202009 7,498.885 109.815 9,213.677
202012 7,682.279 109.897 9,431.974
202103 8,524.645 111.754 10,292.224
202106 10,419.013 114.631 12,263.673
202109 11,622.702 115.734 13,550.103
202112 12,769.001 117.630 14,646.648
202203 19,090.248 121.301 21,234.633
202206 11,901.814 125.017 12,845.244
202209 11,881.391 125.227 12,801.729
202212 12,655.445 125.222 13,636.253
202303 16,114.966 127.348 17,074.010
202306 17,899.621 128.729 18,761.434
202309 22,068.103 129.860 22,929.197
202312 21,418.349 129.419 22,329.767
202403 22,414.033 131.776 22,949.890
202406 23,141.121 132.554 23,555.362
202409 24,134.872 133.029 24,479.164
202412 28,813.748 133.157 29,196.649
202503 22,436.364 134.927 22,436.364

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Regeneron Pharmaceuticals  (MIC:REGN-RM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Regeneron Pharmaceuticals was 61.08. The lowest was 3.43. And the median was 11.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Regeneron Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Regeneron Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Regeneron Pharmaceuticals Business Description

Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Regeneron Pharmaceuticals Headlines

No Headlines